{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:43:52Z","timestamp":1791020632388,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1124\/jpet.106.106971","type":"journal-article","created":{"date-parts":[[2006,10,4]],"date-time":"2006-10-04T02:35:51Z","timestamp":1159929351000},"page":"64-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"title":["Cannabinoid (CB1) Receptor Activation Inhibits Trigeminovascular Neurons"],"prefix":"10.1016","volume":"320","author":[{"given":"Simon","family":"Akerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Goadsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.106.106971_bib1","doi-asserted-by":"crossref","unstructured":"Adams IB, Ryan W, Singer M, Thomas BF, Compton DR, Razdan RK, and Martin BR (1995) Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. J Pharmacol Exp Ther 273: 1172\u20131181.","DOI":"10.1016\/S0022-3565(25)09592-8"},{"key":"10.1124\/jpet.106.106971_bib2","doi-asserted-by":"crossref","unstructured":"Akerman S, Kaube H, and Goadsby PJ (2004a) Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors. Br J Pharmacol 142: 1354\u20131360.","DOI":"10.1038\/sj.bjp.0705896"},{"key":"10.1124\/jpet.106.106971_bib3","doi-asserted-by":"crossref","unstructured":"Akerman S, Kaube H, and Goadsby PJ (2004b) Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. J Pharmacol Exp Ther 309: 56\u201363.","DOI":"10.1124\/jpet.103.059808"},{"key":"10.1124\/jpet.106.106971_bib4","doi-asserted-by":"crossref","unstructured":"Andlin-Sobocki P, Jonsson B, Wittchen HU, and Olesen J (2005) Cost of disorders of the brain in Europe. Eur J Neurol 12: 1\u201327.","DOI":"10.1111\/j.1468-1331.2005.01202.x"},{"key":"10.1124\/jpet.106.106971_bib5","doi-asserted-by":"crossref","unstructured":"Bartsch T, Knight YE, and Goadsby PJ (2004) Activation of 5-HT1B\/1D receptors in the periaqueductal grey inhibits meningeal nociception. Ann Neurol 56: 371\u2013381.","DOI":"10.1002\/ana.20193"},{"key":"10.1124\/jpet.106.106971_bib6","doi-asserted-by":"crossref","unstructured":"Bereiter DA, Bereiter DF, and Hirata H (2002) Topical cannabinoid agonist, WIN55,212-2, reduces cornea-evoked trigeminal brainstem activity in the rat. Pain 99: 547\u2013556.","DOI":"10.1016\/S0304-3959(02)00271-3"},{"key":"10.1124\/jpet.106.106971_bib7","doi-asserted-by":"crossref","unstructured":"Crawley JN, Corwin RL, Robinson JK, Felder CC, Devane WA, and Axelrod J (1993) Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol Biochem Behav 46: 967\u2013972.","DOI":"10.1016\/0091-3057(93)90230-Q"},{"key":"10.1124\/jpet.106.106971_bib8","doi-asserted-by":"crossref","unstructured":"Cumberbatch MJ, Hill RG, and Hargreaves RJ (1998) The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats. Eur J Pharmacol 362: 43\u201346.","DOI":"10.1016\/S0014-2999(98)00764-X"},{"key":"10.1124\/jpet.106.106971_bib9","doi-asserted-by":"crossref","unstructured":"Cupini LM, Bari M, Battista N, Argiro G, Finazzi-Agro A, Calabresi P, and Maccarrone M (2006) Biochemical changes in endocannabinoid system are expressed in platelets of female but not male migraineurs. Cephalalgia 26: 277\u2013281.","DOI":"10.1111\/j.1468-2982.2005.01031.x"},{"key":"10.1124\/jpet.106.106971_bib10","doi-asserted-by":"crossref","unstructured":"Evans RW and Ramadan NM (2004) Are cannabis-based chemicals helpful in headache? Headache 44: 726\u2013727.","DOI":"10.1111\/j.1526-4610.2004.04133C.x"},{"key":"10.1124\/jpet.106.106971_bib11","doi-asserted-by":"crossref","unstructured":"Farquhar-Smith WP, Egertova M, Bradbury EJ, McMahon SB, Rice AS, and Elphick MR (2000) Cannabinoid CB(1) receptor expression in rat spinal cord. Mol Cell Neurosci 15: 510\u2013521.","DOI":"10.1006\/mcne.2000.0844"},{"key":"10.1124\/jpet.106.106971_bib12","doi-asserted-by":"crossref","unstructured":"Felder CC, Briley EM, Axelrod J, Simpson JT, Mackie K, and Devane WA (1993) Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc Natl Acad Sci USA 90: 7656\u20137660.","DOI":"10.1073\/pnas.90.16.7656"},{"key":"10.1124\/jpet.106.106971_bib13","unstructured":"Field A (2000) Discovering Statistics Using SPSS for Windows. SAGE Publications, London."},{"key":"10.1124\/jpet.106.106971_bib14","doi-asserted-by":"crossref","unstructured":"Glaser ST, Abumrad NA, Fatade F, Kaczocha M, Studholme KM, and Deutsch DG (2003) Evidence against the presence of an anandamide transporter. Proc Natl Acad Sci USA 100: 4269\u20134274.","DOI":"10.1073\/pnas.0730816100"},{"key":"10.1124\/jpet.106.106971_bib15","doi-asserted-by":"crossref","unstructured":"Goadsby PJ (2005) Can we develop neurally-acting drugs for the treatment of migraine? Nat Rev Drug Discov 4: 741\u2013750.","DOI":"10.1038\/nrd1822"},{"key":"10.1124\/jpet.106.106971_bib16","doi-asserted-by":"crossref","unstructured":"Goadsby PJ, Lipton RB, and Ferrari MD (2002) Migraine\u2014current understanding and treatment. N Eng J Med 346: 257\u2013270.","DOI":"10.1056\/NEJMra010917"},{"key":"10.1124\/jpet.106.106971_bib17","doi-asserted-by":"crossref","unstructured":"Harris J, Drew LJ, and Chapman V (2000) Spinal anandamide inhibits nociceptive transmission via cannabinoid receptor activation in vivo. Neuroreport 11: 2817\u20132819.","DOI":"10.1097\/00001756-200008210-00041"},{"key":"10.1124\/jpet.106.106971_bib18","doi-asserted-by":"crossref","unstructured":"Hogestatt ED, Jonsson BA, Ermund A, Andersson DA, Bjork H, Alexander JP, Cravatt BF, Basbaum AI, and Zygmunt PM (2005) Conversion of acetaminophen to the bioactive N- acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem 280: 31405\u201331412.","DOI":"10.1074\/jbc.M501489200"},{"key":"10.1124\/jpet.106.106971_bib19","doi-asserted-by":"crossref","unstructured":"Hohmann AG and Herkenham M (1999) Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. Neuroscience 90: 923\u2013931.","DOI":"10.1016\/S0306-4522(98)00524-7"},{"key":"10.1124\/jpet.106.106971_bib20","doi-asserted-by":"crossref","unstructured":"Hu JW, Dostrovsky JO, and Sessle BJ (1981) Functional properties of neurons in cat trigeminal subnucleus caudalis (medullary dorsal horn). I. Responses to oral-facial noxious and nonnoxious stimuli and projections to thalamus and subnucleus oralis. J Neurophysiol 45: 173\u2013192.","DOI":"10.1152\/jn.1981.45.2.173"},{"key":"10.1124\/jpet.106.106971_bib21","doi-asserted-by":"crossref","unstructured":"Ichikawa H and Sugimoto T (2001) VR1-immunoreactive primary sensory neurons in the rat trigeminal ganglion. Brain Res 890: 184\u2013188.","DOI":"10.1016\/S0006-8993(00)03253-4"},{"key":"10.1124\/jpet.106.106971_bib22","doi-asserted-by":"crossref","unstructured":"Kelly S and Chapman V (2001) Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo. J Neurophysiol 86: 3061\u20133064.","DOI":"10.1152\/jn.2001.86.6.3061"},{"key":"10.1124\/jpet.106.106971_bib23","doi-asserted-by":"crossref","unstructured":"LaBuda CJ and Little PJ (2005) Pharmacological evaluation of the selective spinal nerve ligation model of neuropathic pain in the rat. J Neurosci Methods 144: 175\u2013181.","DOI":"10.1016\/j.jneumeth.2004.11.008"},{"key":"10.1124\/jpet.106.106971_bib24","doi-asserted-by":"crossref","unstructured":"Lambert GA, Lowy AJ, Boers P, Angus-Leppan H, and Zagami A (1992) The spinal cord processing of input from the superior sagittal sinus: pathway and modulation by ergot alkaloids. Brain Res 597: 321\u2013330.","DOI":"10.1016\/0006-8993(92)91489-2"},{"key":"10.1124\/jpet.106.106971_bib25","doi-asserted-by":"crossref","unstructured":"MacIver MB and Tanelian DL (1993) Free nerve ending terminal morphology is fiber type specific for A delta and C fibers innervating rabbit corneal epithelium. J Neurophysiol 69: 1779\u20131783.","DOI":"10.1152\/jn.1993.69.5.1779"},{"key":"10.1124\/jpet.106.106971_bib26","doi-asserted-by":"crossref","unstructured":"Mackie K, Lai Y, Westenbroek R, and Mitchell R (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 15: 6552\u20136561.","DOI":"10.1523\/JNEUROSCI.15-10-06552.1995"},{"key":"10.1124\/jpet.106.106971_bib27","doi-asserted-by":"crossref","unstructured":"Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, and Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (Lond) 346: 561\u2013564.","DOI":"10.1038\/346561a0"},{"key":"10.1124\/jpet.106.106971_bib28","doi-asserted-by":"crossref","unstructured":"Menken M, Munsat TL, and Toole JF (2000) The global burden of disease study\u2014implications for neurology. Arch Neurol 57: 418\u2013420.","DOI":"10.1001\/archneur.57.3.418"},{"key":"10.1124\/jpet.106.106971_bib29","doi-asserted-by":"crossref","unstructured":"Millan MJ (1999) The induction of pain: an integrative review. Prog Neurobiol 57: 1\u2013164.","DOI":"10.1016\/S0301-0082(98)00048-3"},{"key":"10.1124\/jpet.106.106971_bib30","doi-asserted-by":"crossref","unstructured":"Munro S, Thomas KL, and Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature (Lond) 365: 61\u201365.","DOI":"10.1038\/365061a0"},{"key":"10.1124\/jpet.106.106971_bib31","doi-asserted-by":"crossref","unstructured":"Pacher P, Batkai S, and Kunos G (2004) Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice. J Physiol (Lond) 558: 647\u2013657.","DOI":"10.1113\/jphysiol.2004.064824"},{"key":"10.1124\/jpet.106.106971_bib32","doi-asserted-by":"crossref","unstructured":"Papanastassiou AM, Fields HL, and Meng ID (2004) Local application of the cannabinoid receptor agonist, WIN 55,212-2, to spinal trigeminal nucleus caudalis differentially affects nociceptive and non-nociceptive neurons. Pain 107: 267\u2013275.","DOI":"10.1016\/j.pain.2003.11.009"},{"key":"10.1124\/jpet.106.106971_bib33","doi-asserted-by":"crossref","unstructured":"Price TJ, Helesic G, Parghi D, Hargreaves KM, and Flores CM (2003) The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat. Neuroscience 120: 155\u2013162.","DOI":"10.1016\/S0306-4522(03)00333-6"},{"key":"10.1124\/jpet.106.106971_bib34","doi-asserted-by":"crossref","unstructured":"Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, and Flores CM (2004) Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons. Br J Pharmacol 142: 257\u2013266.","DOI":"10.1038\/sj.bjp.0705778"},{"key":"10.1124\/jpet.106.106971_bib35","doi-asserted-by":"crossref","unstructured":"Ray BS and Wolff HG (1940) Experimental studies on headache. Pain sensitive structures of the head and their significance in headache. Arch Surg 41: 813\u2013856.","DOI":"10.1001\/archsurg.1940.01210040002001"},{"key":"10.1124\/jpet.106.106971_bib36","doi-asserted-by":"crossref","unstructured":"Russo E (1998) Cannabis for migraine treatment: the once and future prescription? An historical and scientific review. Pain 76: 3\u20138.","DOI":"10.1016\/S0304-3959(98)00033-5"},{"key":"10.1124\/jpet.106.106971_bib37","doi-asserted-by":"crossref","unstructured":"Shields KG and Goadsby PJ (2005) Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine? Brain 128: 86\u201397.","DOI":"10.1093\/brain\/awh298"},{"key":"10.1124\/jpet.106.106971_bib38","doi-asserted-by":"crossref","unstructured":"Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R, and Martin BR (1994) The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharmacol Exp Ther 270: 219\u2013227.","DOI":"10.1016\/S0022-3565(25)22356-4"},{"key":"10.1124\/jpet.106.106971_bib39","doi-asserted-by":"crossref","unstructured":"Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, and Lipton RB (2003) The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia 23: 519\u2013527.","DOI":"10.1046\/j.1468-2982.2003.00568.x"},{"key":"10.1124\/jpet.106.106971_bib40","doi-asserted-by":"crossref","unstructured":"Tsou K, Brown S, Sanudo-Pena MC, Mackie K, and Walker JM (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83: 393\u2013411.","DOI":"10.1016\/S0306-4522(97)00436-3"},{"key":"10.1124\/jpet.106.106971_bib41","doi-asserted-by":"crossref","unstructured":"Twitchell W, Brown S, and Mackie K (1997) Cannabinoids inhibit N- and P\/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol 78: 43\u201350.","DOI":"10.1152\/jn.1997.78.1.43"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524331064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524331064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.106.106971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:06:48Z","timestamp":1740002808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524331064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0022356524331064"],"URL":"https:\/\/doi.org\/10.1124\/jpet.106.106971","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoid (CB1) Receptor Activation Inhibits Trigeminovascular Neurons","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.106.106971","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}